Business Context and Reporting Period
Company: Novavax, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 14, 2018
Reporting Period: Fourth Quarter ended December 31, 2017
This filing serves as a current report to announce the Company's financial results for the quarter ended December 31, 2017, and to disclose a significant change in executive leadership.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) containing the specific financial results for the quarter ended December 31, 2017. However, the body of this Form 8-K does not provide specific numerical values for:
- Revenue
- Profit or Net Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: Specific financial figures are not present in the provided text; investors must refer to the attached press release (Exhibit 99.1) for detailed metrics.
Material Changes and Corporate Actions
Executive Appointment
On March 14, 2018, the Board of Directors appointed John J. Trizzino to the following roles:
- Senior Vice President
- Chief Business Officer
- Chief Financial Officer
- Treasurer
Background: Mr. Trizzino, age 58, previously served as Senior Vice President, Commercial Operations since rejoining the Company in 2014. His prior roles at Novavax include Senior Vice President, Business Development (2010–2011) and Senior Vice President, International and Government Alliances (2009–2010). Before rejoining Novavax, he was CEO of Immunovaccine Inc. (2011–2013).
Compensation: Mr. Trizzino is being compensated in accordance with his existing employment agreement dated February 26, 2014.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, forward-looking outlook statements, risk factors, or contingencies beyond the standard legal disclaimers regarding the non-filing status of the press release information under Section 18 of the Exchange Act.
Investor Verification Checklist
- Financial Details: Review Exhibit 99.1 (Press Release) for the actual Q4 2017 revenue, net loss, and cash position figures, as they are not listed in the 8-K body.
- Leadership Transition: Confirm the effective date and specific responsibilities of the new CFO, John J. Trizzino, via Exhibit 99.2.
- Employment Terms: Verify the terms of Mr. Trizzino's compensation by reviewing the employment agreement filed as Exhibit 10.3 to the May 5, 2016 Form 10-Q.
- Legal Status: Note that the financial information in this 8-K is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.